Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.70 |
| ▸ | MEN1 | O00255 | 2/20 | 0.70 |
| ▸ | POLB | P06746 | 1/20 | 0.70 |
| ▸ | APEX1 | P27695 | 1/20 | 0.70 |
| ▸ | RECQL | P46063 | 1/20 | 0.70 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.70 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.70 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.70 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.70 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.70 |
| ▸ | ESR1 | P03372 | 7/20 | 0.68 |
| ▸ | ESR2 | Q92731 | 6/20 | 0.68 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.68 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.68 |
| ▸ | CA12 | O43570 | 1/20 | 0.68 |
| ▸ | SLCO2B1 | O94956 | 1/20 | 0.68 |
| ▸ | TTR | P02766 | 1/20 | 0.68 |
| ▸ | SHBG | P04278 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Succedaneaflavanone SCHEMBL615879 | 0.94 | KMT2A (0.78) | KMT2AMEN1POLBAPEX1RECQL | |
| SCHEMBL476289 | 0.85 | PLK1 (0.80) | KMT2AMEN1POLBAPEX1RECQL | |
| SCHEMBL476401 | 0.85 | PLK1 (0.80) | KMT2AMEN1POLBAPEX1RECQL | |
| SCHEMBL30064298 | 0.85 | PLK1 (0.80) | KMT2AMEN1POLBAPEX1RECQL | |
| SCHEMBL7618316 | 0.85 | KMT2A (0.60) | KMT2AMEN1POLBAPEX1RECQL | |
| SCHEMBL4758120 | 0.84 | ESR1 (0.75) | KMT2AMEN1POLBAPEX1RECQL | |
| SCHEMBL476381 | 0.84 | ESR1 (0.75) | KMT2AMEN1POLBAPEX1RECQL | |
| SCHEMBL24406183 | 0.82 | KMT2A (1.00) | KMT2AMEN1POLBAPEX1RECQL | |
| SCHEMBL29906199 | 0.82 | KMT2A (1.00) | KMT2AMEN1POLBAPEX1RECQL | |
| SCHEMBL29099768 | 0.82 | KMT2A (1.00) | KMT2AMEN1POLBAPEX1RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119504683-B | Method for separating biflavanoid compounds from clematis bud and application thereof | 西北大学 | 2026-05-19 | — | — | CN | claimed |
| CN-119504683-A | Method for separating biflavanoid compounds from clematis bud and application thereof | 西北大学 | 2025-02-25 | — | — | CN | claimed |
| CN-103221056-A | Electronically Modified Reaction Intermediates | MARKOU DEMETRIOS | 2013-07-24 | — | — | CN | claimed |
| EP-2603225-A2 | ELECTRONICALLY MODIFIED REACTION INTERMIDEATES | Markou, Demetrios (US) | 2013-06-19 | — | — | EP | claimed |
| WO-2012024196-A2 | A NOVEL METHOD FOR CREATING, SUSPENDING AND STABILIZING ELECTRONICALLY MODIFIED REACTION INTERMIDEATES | MARKOU DEMETRIOS (US) | 2012-02-23 | — | — | WO | claimed |
| US-20120039796-A1 | Novel method for creating, suspending and stabilizing electronically modified oxygen derivatives, along with creating, suspending and stabilizing electronically modified reaction intermediates, in a bio compatible fluorocarbon suspension, for the purpose of inducing a cascading immune response in mammalian patients | MARKOU DEMETRIOS (US) | 2012-02-16 | — | — | US | claimed |
| US-20020068757-A1 | Biflavanoids and derivatives thereof as antiviral agents | ADVANCED LIFE SCIENCES, INC. | 2002-06-06 | — | — | US | claimed |
| US-6399654-B1 | ADMINISTERING MIXTURE OF VIRICIDE AND BIOFLAVANOID | ADVANCED LIFE SCIENCES, INC. | 2002-06-04 | — | — | US | claimed |
| WO-1998046238-A1 | BIFLAVINOIDS AND DERIVATIVES THEREOF AS ANTIVIRAL AGENTS, ALONE OR IN COMBINATION WITH AT LEAST ONE KNOWN ANTIVIRAL AGENT | MEDICHEM RESEARCH, INC. (US) | 1998-10-22 | — | — | WO | claimed |
| EP-0833631-A1 | BIFLAVANOIDS AND DERIVATIVES THEREOF AS ANTIVIRAL AGENTS | MEDICHEM RESEARCH, INC. (US) | 1998-04-08 | — | — | EP | claimed |
| WO-1997000679-A1 | BIFLAVANOIDS AND DERIVATIVES THEREOF AS ANTIVIRAL AGENTS | MEDICHEM RESEARCH, INC. (US) | 1997-01-09 | — | — | WO | claimed |
| CN-119504683-B | Method for separating biflavanoid compounds from clematis bud and application thereof | 西北大学 | 2026-05-19 | — | — | CN | disclosed |
| CN-119504683-B | Method for separating biflavanoid compounds from clematis bud and application thereof | 西北大学 | 2026-05-19 | — | — | CN | disclosed |
| CN-119504683-A | Method for separating biflavanoid compounds from clematis bud and application thereof | 西北大学 | 2025-02-25 | — | — | CN | disclosed |
| CN-119504683-A | Method for separating biflavanoid compounds from clematis bud and application thereof | 西北大学 | 2025-02-25 | — | — | CN | disclosed |
| US-5773462-A | INFLUENZA THERAPY | MEDICHEM RESEARCH, INC. (US) | 1998-06-30 | — | — | US | disclosed |
| EP-0833631-A1 | BIFLAVANOIDS AND DERIVATIVES THEREOF AS ANTIVIRAL AGENTS | MEDICHEM RESEARCH, INC. (US) | 1998-04-08 | — | — | EP | disclosed |
| EP-0833631-A1 | BIFLAVANOIDS AND DERIVATIVES THEREOF AS ANTIVIRAL AGENTS | MEDICHEM RESEARCH, INC. (US) | 1998-04-08 | — | — | EP | disclosed |
| WO-1997000679-A1 | BIFLAVANOIDS AND DERIVATIVES THEREOF AS ANTIVIRAL AGENTS | MEDICHEM RESEARCH, INC. (US) | 1997-01-09 | — | — | WO | disclosed |
| WO-1997000679-A1 | BIFLAVANOIDS AND DERIVATIVES THEREOF AS ANTIVIRAL AGENTS | MEDICHEM RESEARCH, INC. (US) | 1997-01-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020068757-A1 | Biflavanoids and derivatives thereof as antiviral agents | HK2, GYS2, HK1 | KMT2A 463/4885MEN1 836/4885POLB 3037/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.